Ildong Pharmaceutical financials at a glance

+ Portfolio

The revenue of Ildong Pharmaceutical is reported as 597.93 billion Won in the fiscal year 2023. The earnings were -3338 Won per share in 2023, which was 37.76 higher than 2022. And about -109.20146 billion Won are reported as free cash flow in the financials of Ildong Pharmaceutical 2023. No dividends were paid to the shareholders of the Ildong Pharmaceutical stock KOSE:A249420 in the financial year 2023.

₩597.93B

Revenue

₩-3,338.00

Earnings Per Share

35.56%

Gross Margin %

₩-,101,000.00M

Free Cash Flow

Revenue

597,930.00

Earnings Per Share

-3,338.00

Gross Margin %

35.56

Free Cash Flow

-,101,000.00

Financials

Year	Year	TTM	2023	2022	2019	2018	2017
Rev.	Revenue	N/A	₩597.93B	₩635.81B	₩516.82B	₩503.50B	₩461.19B
GM %	Gross Margin %	35.66%	35.56%	37.03%	44.85%	50.59%	49.07%
OM	Operating Margin	-12.25%	-8.89%	-11.55%	-0.30%	5.39%	5.51%
EPS	Earnings Per Share	₩-5,012.55	₩-3,338.00	₩-5,363.00	₩-,598.00	₩534.29	₩896.15
Div.	Dividends	N/A	₩0.00	₩0.00	₩380.95	₩380.95	₩362.81
PR %	Payout Ratio %	0	0	0	-63.70%	71.30%	40.49%
Sha.	Shares	N/AM	27.93M	26.79M	22.66M	22.66M	21.63M
OCF	Operating Cash Flow	N/A	₩-96,000.00M	₩-69,000.00M	₩40.41B	₩65.40B	₩72.29B
FCF	Free Cash Flow	N/A	₩-,101,000.00M	₩-54,000.00M	₩28.37B	₩50.67B	₩55.93B
FCFS	Free Cash Flow Per Share	₩-3,228.81	₩-1,915.83	₩-2,726.05	₩1.01k	₩1.94k	₩1.31k

Ildong Pharmaceutical financials at a glance

Financials

Discover